A case of multiple myeloma in a patient in treatment for chronic lymphocytic leukemia

Main Article Content

Mario Biglietto
Array
https://orcid.org/0000-0003-1487-5812
Ugo Coppetelli
Hematology and Transplant Unit, Santa Maria Goretti Hospital, AUSL, Latina, Italy

Luciano Fiori
Hematology and Transplant Unit, Santa Maria Goretti Hospital, AUSL, Latina, Italy

Martina Gherardini
Hematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Italy

Raffaele Maglione
Hematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Italy

Alessandro Pulsoni
Hematology and Transplant Unit, Santa Maria Goretti Hospital, AUSL, Latina, Italy

Azzurra Anna Romeo
Hematology and Transplant Unit, Santa Maria Goretti Hospital, AUSL, Latina, Italy

Keywords

Multiple myeloma, Chronic Lymphocytic Leukaemia, Concomitant treatment, Bellini trial

Abstract

Synchronous and sequential diagnosis of Multiple Myeloma (MM) and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) is a rare event with no cases described with a need for concomitant treatment for both diseases. Here we describe a case of a 58 years old male patient diagnosed with CLL and then MM, needing concomitant treatment for both diseases. We treated the patient with a BELLINI trial-like regimen including Bortezomib, Venetoclax and Dexamethasone, obtaining a good response for both the malignancies.

Downloads

Download data is not yet available.


Abstract 308
PDF Downloads 203
HTML Downloads 67

Article Sidebar

PDF HTML
Published
Apr 30, 2025
DOI https://doi.org/10.4084/MJHID.2025.033

Article Details

How to Cite

Biglietto, M. (2025) “A case of multiple myeloma in a patient in treatment for chronic lymphocytic leukemia”, Mediterranean Journal of Hematology and Infectious Diseases, 17(1), p. e2025033. doi: 10.4084/MJHID.2025.033.
Issue
Vol. 17 No. 1 (2025): Review Articles, Original Article, Scientific Letter, Case Reports Letter to the Editor
Section
Scientific Letters
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Transfer of Copyright and Permission to Reproduce Parts of Published Papers. Authors will grant copyright of their articles to the Institute of Hematology, Catholic University, Rome . No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.